LOGISTICS & WAREHOUSING
Kuehne + Nagel has expanded its healthcare logistics footprint in India by opening a new temperature-controlled airfreight cross-dock facility in Hyderabad. As a major pharmaceutical hub, Hyderabad produces over 40 percent of India’ s active pharma ingredients and vaccines. Strategically located near key manufacturing sites, the new 248-square-meter facility supports the efficient, secure distribution of medical cargo.
Operating with dedicated zones ranging from + 2 ° C to + 8 ° C and + 15 ° C to + 25 ° C, the facility protects product integrity across diverse climate-sensitive shipments. It meets the company’ s global HealthChain quality standard
to ensure strict GxP supply chain compliance. This marks Kuehne + Nagel’ s second HealthChain-certified hub in India, building on its Bengaluru Cool Zone facility launched in December 2025.
Anish Kumar Jha, Managing Director for Kuehne + Nagel India, Sri Lanka and the Maldives, says:“ This investment strengthens our healthcare logistics network in India and brings us closer to customers operating in one of the country’ s most important pharmaceutical hubs. By investing in specialised, HealthChain-certified infrastructure, we are supporting Indian healthcare companies as they grow and connect to global markets through compliant, temperature-controlled supply chains.” supplychaindigital. com 127